Drug Shortage Report for SURVANTA
Report ID | 56829 |
Drug Identification Number | 02016109 |
Brand name | SURVANTA |
Common or Proper name | SURVANTA VIAL, 4mL |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | BERACTANT |
Strength(s) | 25MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRATRACHEAL |
Packaging size | 4mL vial |
ATC code | R07AA |
ATC description | OTHER RESPIRATORY SYSTEM PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-07-24 |
Estimated end date | 2018-09-04 |
Actual end date | 2018-08-29 |
Shortage status | Resolved |
Updated date | 2018-08-30 |
Company comments | We are currently monitoring our inventory of Survanta 4mL due to an unexpected increase in market demand. We have normal inventory levels of Survanta 8mL. During that period, orders will be processed to prioritize patient needs. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-07-27 | English | Compare |
v2 | 2018-07-27 | English | Compare |
v3 | 2018-07-27 | English | Compare |
v4 | 2018-07-27 | French | Compare |
v5 | 2018-07-27 | English | Compare |
v6 | 2018-07-27 | French | Compare |
v7 | 2018-08-30 | English | Compare |
v8 | 2018-08-30 | French | Compare |
Showing 1 to 8 of 8